Literature DB >> 27168664

Integrating Routine HCV Testing in Primary Care: Lessons Learned from Five Federally Qualified Health Centers in Philadelphia, Pennsylvania, 2012-2014.

Catelyn Coyle1, Helena Kwakwa2, Kendra Viner3.   

Abstract

OBJECTIVE: An estimated 2.7-3.9 million Americans are infected with hepatitis C virus (HCV). Despite being the most common blood-borne virus in the United States, routine HCV testing is not commonly practiced. To address this gap, we measured the impact of integrated routine HCV testing on patient care.
METHODS: As part of CDC's Hepatitis Testing and Linkage to Care initiative, which promoted viral hepatitis B and hepatitis C screening, posttest counseling, and linkage to care at 34 U.S. sites, National Nursing Centers Consortium integrated a routine opt-out HCV testing and linkage-to-care model at five federally qualified health centers in Philadelphia, Pennsylvania, from October 1, 2012, to June 30, 2014. The model included medical assistant-initiated testing, reflex laboratory-based HCV tests, and electronic health record modifications to prompt, track, and facilitate reimbursement for tests performed on uninsured patients.
RESULTS: During the study period, 4,207 unique patients received HCV antibody (anti-HCV) testing, of whom 488 (11.6%) tested anti-HCV positive. Of those testing positive, 433 (88.7%) received a confirmatory HCV RNA test; of these 433 recipients, 313 (72.3%) were diagnosed with current infection (overall prevalence = 7.4%), of which 243 (77.6%) received their HCV RNA-positive results, 184 (58.8%) were referred to an HCV care provider, and 121 (38.7%) were linked to care. The highest rates of current infection were among non-Hispanic white patients (18.1%, 90/496); patients from the Public Health Management Corporation Care Clinic, which treats HIV and HCV patients on-site (14.3%, 200/1,394); and patients aged 50-69 years (10.7%, 189/1,767).
CONCLUSION: Our model successfully integrated HCV testing and linkage to care into routine primary care. This study also identified potential successes and barriers that may be experienced by other primary care health centers that are integrating HCV testing.

Entities:  

Mesh:

Year:  2016        PMID: 27168664      PMCID: PMC4853331          DOI: 10.1177/00333549161310S211

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  22 in total

1.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

2.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

3.  Dual-Routine HCV/HIV Testing: Seroprevalence and Linkage to Care in Four Community Health Centers in Philadelphia, Pennsylvania.

Authors:  Catelyn Coyle; Helena Kwakwa
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

4.  Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-05-06       Impact factor: 17.586

5.  The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

Authors:  Kathleen N Ly; Jian Xing; R Monina Klevens; Ruth B Jiles; John W Ward; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2012-02-21       Impact factor: 25.391

6.  Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009-2010.

Authors:  Rania A Tohme; Jian Xing; Youlian Liao; Scott D Holmberg
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

7.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

8.  The natural history of hepatitis C virus (HCV) infection.

Authors:  Stephen L Chen; Timothy R Morgan
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

Review 9.  Ending hepatitis C in the United States: the role of screening.

Authors:  Phillip O Coffin; Andrew Reynolds
Journal:  Hepat Med       Date:  2014-07-03

Review 10.  The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis.

Authors:  Baligh R Yehia; Asher J Schranz; Craig A Umscheid; Vincent Lo Re
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

View more
  16 in total

1.  Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.

Authors:  Tengiz Tsertsvadze; Amiran Gamkrelidze; Nikoloz Chkhartishvili; Akaki Abutidze; Lali Sharvadze; Vakhtang Kerashvili; Maia Butsashvili; David Metreveli; Lia Gvinjilia; Shaun Shadaker; Muazzam Nasrullah; Ekaterine Adamia; Stefan Zeuzem; Nezam Afdhal; Sanjeev Arora; Karla Thornton; Beth Skaggs; Tinatin Kuchuloria; Maia Lagvilava; David Sergeenko; Francisco Averhoff
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

2.  Hepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era.

Authors:  Alexander J Millman; Noele P Nelson; Claudia Vellozzi
Journal:  Curr Epidemiol Rep       Date:  2017-04-20

3.  Improving support and education of low-income baby boomers diagnosed with chronic hepatitis C virus infection through universal screening.

Authors:  Barbara J Turner; Kathryn Craig; Vidhi S Makanji; Bertha E Flores; Ludivina Hernandez
Journal:  J Clin Nurs       Date:  2017-05-23       Impact factor: 3.036

4.  Universal HCV Screening of Baby Boomers is Feasible, but It is Difficult.

Authors:  Paul J Thuluvath; Joshua Trowell; Talan Zhang; Joseph Alukal; George Lowe
Journal:  J Clin Exp Hepatol       Date:  2021-02-25

5.  Increasing Hepatitis C Screening in a Federally Qualified Health Center: A Quality Improvement Initiative.

Authors:  Melissa D Klein; Bryna J Harrington; Joan East; Jennifer Cunningham; Nicole Ifill; Jan Lee Santos
Journal:  J Healthc Qual       Date:  2021 Sep-Oct 01       Impact factor: 1.095

6.  Patient and provider-level barriers to hepatitis C screening and linkage to care: A mixed-methods evaluation.

Authors:  Robin T Higashi; Mamta K Jain; Lisa Quirk; Nicole E Rich; Akbar K Waljee; Barbara J Turner; Simon Craddock Lee; Amit G Singal
Journal:  J Viral Hepat       Date:  2020-03-02       Impact factor: 3.728

7.  Prevalence of Hepatitis C Screening, Testing, and Care Experience Among Young Adults Who Use Prescription Opioids Nonmedically.

Authors:  Ayorinde I Soipe; Lynn E Taylor; Ajibola I Abioye; Traci C Green; Scott E Hadland; Brandon D L Marshall
Journal:  J Adolesc Health       Date:  2017-10-25       Impact factor: 5.012

8.  Improved Hepatitis C Cure Cascade Outcomes Among Urban Baby Boomers in the Direct-Acting Antiviral Era.

Authors:  Sarah C Dupont; Shelly-Ann Fluker; Kristi M Quairoli; Cameron Body; Ike Okosun; Jennifer Lom; Lesley S Miller
Journal:  Public Health Rep       Date:  2019-11-22       Impact factor: 2.792

9.  Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C Virus.

Authors:  Sammy Saab; Timothy Ahn; Terina McDaniel; Beshoy Yanny; Myron J Tong
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-08

10.  Testing for Hepatitis C in Pregnancy: the Time has Come for Routine Rather than Risk-based.

Authors:  Tatyana Kushner; Catherine A Chappell; Arthur Y Kim
Journal:  Curr Hepatol Rep       Date:  2019-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.